Bank of America’s Arcadia Biosciences RKDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12
Closed -$24 6660
2025
Q4
$24 Hold
12
﹤0.01% 7095
2025
Q3
$41 Sell
12
-1
-8% -$4 ﹤0.01% 8053
2025
Q2
$56 Buy
13
+2
+18% +$8 ﹤0.01% 8074
2025
Q1
$33 Hold
11
﹤0.01% 8050
2024
Q4
$65 Hold
11
﹤0.01% 7826
2024
Q3
$30 Hold
11
﹤0.01% 7906
2024
Q2
$35 Buy
+11
New +$28 ﹤0.01% 7911
2022
Q1
Sell
-1
Closed 8675
2021
Q4
$0 Buy
+1
New +$65 ﹤0.01% 8568
2021
Q3
Sell
-1
Closed 8344
2021
Q2
$0 Buy
+1
New +$109 ﹤0.01% 8029
2021
Q1
Sell
-2
Closed 7720
2020
Q4
$0 Buy
+2
New +$244 ﹤0.01% 7323
2020
Q3
Sell
-1
Closed 7132
2020
Q2
$0 Buy
+1
New +$156 ﹤0.01% 7084
2019
Q1
Hold
0
7368
2018
Q4
Hold
0
7339
2016
Q4
Sell
-6
Closed -$9K 7266
2016
Q3
$9K Buy
6
+3
+100% +$5.3K ﹤0.01% 6431
2016
Q2
$7K Buy
3
+2
+200% +$3.35K ﹤0.01% 6603
2016
Q1
$3K Buy
+1
New +$2.13K ﹤0.01% 6707
2015
Q4
Hold
0
7198
2015
Q3
Hold
0
7371
2015
Q2
Hold
0
7380

Other funds holding RKDA

Bank of America's RKDA Position: Q1 2026 in Review

Bank of America sold out of Arcadia Biosciences (RKDA) in Q1 2026, closing a stake of 12 shares — an estimated $24 sold.

Bank of America first reported a position in RKDA in Q1 2016 and held it in 14 quarters. The position peaked at $9K in Q3 2016. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

  • Bank of America reported no remaining Arcadia Biosciences position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 12 Arcadia Biosciences shares in Q1 2026, an estimated $24.
  • Bank of America first reported a position in Arcadia Biosciences in Q1 2016 and held it in 14 quarters.
  • Bank of America's Arcadia Biosciences position peaked at $9K in Q3 2016.
  • 16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.